Fact Based List:
Highlights from AAM's Generic & Biosimilar Medicines Savings Report
Submitted by Patty Jamison on Tue, 10/24/2023 - 13:19
- Total Generic and Biosimilar Savings for 2022: $408 billion
- Total Generic and Biosimilar Savings for Past 10 years: more than $2.9 trillion
- Total Generic and Biosimilar Savings in Medicare for 2022: $130 Billion
- Total Generic and Biosimilar Savings in Commercial Plans for 2022: $194 Billion
- Generics represent 90% of prescriptions filled but only 17.5% of prescription drug spending
- Generics represent less than 2% of all health care spending
Source: AAM, Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022, September 6, 2023
Source URL: https://accessiblemeds.org/resources/press-releases/generic-...
List Ratings: |
Lists You Might Also Be Interested In
- Top 10 Government Issues for Practices to Watch Out for in 2012
- MSSP Estimated Savings from 2013 to 2021: 4 Takeaways
- Foley: 2017 Telemedicine and Digital Health Survey, 5 Takeaways
- Rick Kam and James Christiansen: 4 pillars of trust for the new health insurance exchanges
- Recent Key Trends and Statistics on Obesity
Login or register to post comments